@Article{Uzdrowska2017,
journal="Klinika Oczna / Acta Ophthalmologica Polonica",
issn="0023-2157",
volume="119",
number="1",
year="2017",
title="The influence of anti-VEGF therapy on binocular vision in patients 
with age-related macular degeneration",
abstract=" Purpose : To assess binocular vision quality in patients with age-related macular degeneration and to evaluate the effect of the treatment on binocular vision in these patients.  	 Material and methods : Subjective visual acuity, simultaneous perception, fusion and stereopsis were assessed before anti-VEGF treatment and after the third intravitreal injection in 24 patients with neovascular age-related macular degeneration.  	 Results : Most patients (66.7%) had partially preserved binocular vision and 1/3 of the group presented with suppression. Some patients with suppression gained partial binocular vision after treatment, whereas others, presenting with some degree of bino­cular vision before treatment, lost it after therapy. Anti-VEGF treatment caused a change in the refractive error in 50.0% of the group, and a change of a dominant eye in 3 patients. Strabismus was diagnosed in 25.0% of patients. Treatment-related improvement of visual acuity was not equivalent to the qualitative improvement in binocular vision.  	 Conclusion : The anti-VEGF therapy has a significant impact on binocular vision in treated patients. However, impairment of central vision in age-related macular degeneration does not affect all levels of binocular vision, so visual acuity testing before and after treatment cannot be the only predictor of changes in binocularity. Thus, a standard vision examination in patients treated with anti-VEGF agents should be extended to include binocular vision assessment.",
author="Uzdrowska, Marta
and Bilińska, Ewa
and Broniarczyk-Loba, Anna",
pages="44--47",
doi="10.5114/ko.2017.71767",
url="http://dx.doi.org/10.5114/ko.2017.71767"
}